DEF 14AThe Ballot
Allogene Therapeutics, Inc. files DEF 14A
Filed Apr 26, 2022 · 4y ago · Accession 0001737287-22-000026
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Allogene Therapeutics, Inc.
- Ticker
- ALLO
- CIK
- 1737287
- Form type
- DEF 14A
- Filing date
- Apr 26, 2022
- Report date
- Jun 15, 2022
- Document
- allo-20220414xdef14axdefin.htm
- Size
- 1.5 MB